Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	View
CYSB2101177	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-09-06	Gan & Lee Pharmaceuticals	view
CYSB2300084	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2023-04-19	Gan & Lee Pharmaceuticals	view
CYSB2200124	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2022-05-31	Gan & Lee Pharmaceuticals	view
CYSB2400040	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-02-09	Gan & Lee Pharmaceuticals	view
CYSB2101104	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-06-25	Gan & Lee Pharmaceuticals	view
CYSB2300032	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2023-02-09	Gan & Lee Pharmaceuticals	view
CYSB2400224	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-08-29	Gan & Lee Pharmaceuticals	view
CXSL2200110	GZR101	GZR-101	Injection	Biological Products(1)	New Drug Application	2022-03-03	Gan & Lee Pharmaceuticals	view
CXSL2200192	GZR4	GZR-4	Injection	Biological Products(1)	New Drug Application	2022-05-05	Gan & Lee Pharmaceuticals	view
CYSB2200233	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2022-09-23	Gan & Lee Pharmaceuticals	view
CYSB2400041	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-02-09	Gan & Lee Pharmaceuticals	view
CXSL2101256	GZR18	GZR-18	Injection	Biological Products(1)	New Drug Application	2021-08-12	Gan & Lee Pharmaceuticals	view
CYSB2400140	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2024-06-01	Gan & Lee Pharmaceuticals	view
CYSB2101049	门冬胰岛素30注射液	Insulin aspart protamine recombinant;insulin aspart recombinant	Injection	Biological Products	Supplementary Application	2021-04-23	Gan & Lee Pharmaceuticals	view
CYSB2300079	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2023-04-05	Gan & Lee Pharmaceuticals	view
CYSB2200154	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2022-06-14	Gan & Lee Pharmaceuticals	view
CYSB2101163	门冬胰岛素注射液	insulin aspart	Injection	Biological Products	Supplementary Application	2021-08-20	Gan & Lee Pharmaceuticals	view
CYSB2300234	精蛋白人胰岛素混合注射液（30R）	human insulin;isophane protamine human insulin	Injection	Biological Products	Supplementary Application	2023-12-21	Gan & Lee Pharmaceuticals	view
CYSB2101050	甘精胰岛素注射液	insulin glargine	Injection	Biological Products	Supplementary Application	2021-04-23	Gan & Lee Pharmaceuticals	view
CXSL2101257	GZR18	GZR-18	Injection	Biological Products(1)	New Drug Application	2021-08-12	Gan & Lee Pharmaceuticals	view